Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), bought 1,200 shares at $1.70 ($2K) on 2024-08-21, disclosed to the SEC on 2024-08-23.
Open-market purchase of $2k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |
| TXMD | BUY | 2019-05-15 | $100K | — | Filing → |